May 12, 2022 / 08:30PM GMT
Operator
Good afternoon and welcome to NovaBay Pharmaceuticals' first-quarter 2022 financial results conference call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead, ma'am.
Jody Cain - LHA Investor Relations - SVP
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel; and Andy Jones, the Company's Chief Financial Officer. I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of the federal securities laws.
These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. In particular, there is uncertainty about the integration of the DERMAdoctor into NovaBay's operations as circumstances beyond the company's control could impact broader economies such as the COVID-19 pandemic and the conflict
Q1 2022 NovaBay Pharmaceuticals Inc Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers